Friday's Small-Cap Winners & Losers
Microvision (MVIS) was on the rise after research firm MDB Capital Group initiated coverage of the company with a buy rating. Microvision, a producer of light scanning technologies for display and imaging products, was gaining 10.3% to $3.01.
Metabolix (MBLX) was rising after naming Matthew Strobeck and Robert Van Nostrand to its board. Strobeck is a senior investment analyst at Westfield Capital Management. He previously served as a consultant to the senior economic adviser to the commissioner of the Food and Drug Administration. Van Nostrand is the senior vice president and chief compliance officer of OSI Pharmaceuticals (OSIP). Shares were up 10.6% to $19.25.
Virco (VIR) surged after the company said third-quarter sales increased 4.5% from last year and that it swung to a profit. Sales reached $73.7 million, up from $70.5 million last year. Virco earned $5.8 million, or 41 cents a share, compared with a loss of $2.2 million and 17 cents a share last year. The company said it expects to incur a loss in the fourth quarter but that it will be narrower than last year's. Shares were gaining 17.8% to $7.55.
Unifi (UFI) slumped after it cut its expectations for the December quarter. The company previously forecast earnings before interest, taxes, depreciation and amortization of $10 million to $12 million, but now it expects actual results to be less than 50% of the original guidance. Unifi was down 28.5% at $1.73.
Corriente Resources (ETQ) was dropping after it said it will temporarily suspend work at its Mirador project in Ecuador because of protests near the site. After a number of ineffective talks with the protesters, the government has asked Corriente to temporarily halt its Mirador activities to help in the negotiating process. Shares were losing 13% to $3.90.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV